Page last updated: 2024-10-30

mecamylamine and Glioma

mecamylamine has been researched along with Glioma in 1 studies

Mecamylamine: A nicotinic antagonist that is well absorbed from the gastrointestinal tract and crosses the blood-brain barrier. Mecamylamine has been used as a ganglionic blocker in treating hypertension, but, like most ganglionic blockers, is more often used now as a research tool.

Glioma: Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wang, ZF1
Tang, XC1

Other Studies

1 other study available for mecamylamine and Glioma

ArticleYear
Huperzine A protects C6 rat glioma cells against oxygen-glucose deprivation-induced injury.
    FEBS letters, 2007, Feb-20, Volume: 581, Issue:4

    Topics: Acetylcholinesterase; Alkaloids; Animals; Bungarotoxins; Cell Hypoxia; Cell Nucleus; Cell Survival;

2007